Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Assets Average (2018 - 2025)

Denali Therapeutics (DNLI) has disclosed Assets Average for 8 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • Quarterly Assets Average fell 22.2% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 22.2% year-over-year, with the annual reading at $1.3 billion for FY2025, 0.36% changed from the prior year.
  • Assets Average for Q4 2025 was $1.1 billion at Denali Therapeutics, down from $1.1 billion in the prior quarter.
  • The five-year high for Assets Average was $1.6 billion in Q1 2021, with the low at $1.1 billion in Q4 2025.
  • Average Assets Average over 5 years is $1.4 billion, with a median of $1.4 billion recorded in 2022.
  • The sharpest move saw Assets Average surged 152.35% in 2021, then dropped 24.85% in 2025.
  • Over 5 years, Assets Average stood at $1.4 billion in 2021, then decreased by 5.83% to $1.3 billion in 2022, then fell by 11.06% to $1.2 billion in 2023, then grew by 18.3% to $1.4 billion in 2024, then fell by 22.2% to $1.1 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.1 billion, $1.1 billion, and $1.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.